HIV Patients in the HCUP Database: A Study of Hospital Utilization and Costs

This study examines the utilization of hospital care by HIV patients in all hospitals in eight states (California, Colorado, Florida, Kansas, New Jersey, New York, Pennsylvania, and South Carolina), and examines the cost of hospital care for HIV patients in six of these states (California, Colorado, Kansas, New Jersey, New York, and South Carolina). The eight states in the sample account for more than 52% of all persons living with AIDS in the United States; the six states account for 39%. The unit of observation in both studies is a hospital admission by a patient with HIV. Hospital data were obtained from the Healthcare Cost and Utilization Project (HCUP), State Inpatient Database (SID), which is maintained by the Agency for Healthcare Research and Quality (AHRQ). The HCUP contains hospital discharge data and is a federal/state/industry partnership to build a multistate health care data system. Using multivariate analytic techniques and data from 2000, results indicate that cost and length of a hospital stay vary significantly across states after accounting for a patient's gender, insurance type, race, age, and number of diagnoses, as well as the teaching status and ownership category of the hospital.

[1]  Michael S Saag,et al.  Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. , 2002, JAMA.

[2]  R. Chaisson,et al.  Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  A. Mocroft,et al.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study , 2003, The Lancet.

[4]  N. Miller,et al.  Trends and Issues in the Medicaid 1915(c) Waiver Program , 1999, Health care financing review.

[5]  F J Hellinger,et al.  The lifetime cost of treating a person with HIV. , 1993, JAMA.

[6]  R. Buchanan,et al.  DataView: Medicaid Home and Community-Based Care Waiver Programs: Providing Services to People With AIDS , 1997, Health care financing review.

[7]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[8]  J. Curran,et al.  The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. , 1986, JAMA.

[9]  Jean M. Mitchell,et al.  Florida's Medicaid AIDS Waiver: An Assessment of Dimensions of Quality , 1995, Health care financing review.

[10]  B. Friedman,et al.  Practical options for estimating cost of hospital inpatient stays. , 2002, Journal of health care finance.

[11]  J A Fleishman,et al.  Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. , 1999, JAMA.

[12]  R. A. Torres,et al.  Impact of combination therapy for HIV infection on inpatient census. , 1997, The New England journal of medicine.

[13]  D. McCaffrey,et al.  The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.

[14]  B. Hirschel.  Beware of drug holidays before HIV salvage therapy. , 2003, The New England journal of medicine.

[15]  Richard D Moore,et al.  Costs of HIV medical care in the era of highly active antiretroviral therapy. , 1999, AIDS.

[16]  J. Reisch,et al.  Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[17]  J. Montaner,et al.  Salvage therapy for HIV-1 infection—the challenge grows , 2000, The Lancet.

[18]  J. M. Mitchell,et al.  Expenditures on services for persons with acquired immunodeficiency syndrome under a Medicaid home and community-based waiver program. Are selection effects important? , 1997, Medical care.

[19]  J. Bartlett,et al.  Combination antiretroviral therapy in HIV infection. An economic perspective. , 1996, PharmacoEconomics.

[20]  Rice Dp,et al.  Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. , 1988, The Journal of medical practice management : MPM.

[21]  T. Louis,et al.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. , 2003, The New England journal of medicine.

[22]  A. Telenti,et al.  Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study , 1999, The Lancet.

[23]  Jayanta Bhattacharya,et al.  The Impact of State Policy on the Costs of HIV Infection , 2001, Medical care research and review : MCRR.

[24]  Koop Ce.  Surgeon General's report on acquired immune deficiency syndrome. , 1986, Journal of the Medical Association of Georgia.

[25]  M. Gill,et al.  The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[26]  P. Kissinger,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.

[27]  C. Gatsonis,et al.  The influence of health-related quality of life and social characteristics on hospital use by patients with AIDS in the Boston Health Study. , 1996, Medical care.

[28]  M. Sande,et al.  Emerging resistance to nonnucleoside reverse transcriptase inhibitors: a warning and a challenge. , 2002, JAMA.

[29]  A. Gafni,et al.  The HAART side of resource allocation. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[30]  H. Lane,et al.  When To Start Therapy for HIV Infection: A Swinging Pendulum in Search of Data , 2003, Annals of Internal Medicine.

[31]  S. Crystal,et al.  New Jersey's Medicaid waiver for acquired immunodeficiency syndrome , 1992, Health Care Financing Review.

[32]  Maria Deloria-Knoll,et al.  Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata , 2003, Annals of Internal Medicine.

[33]  Health-Based Payment for HIV/AIDS in Medicaid Managed Care Programs , 1998, Health care financing review.

[34]  Profile of Medicare Beneficiaries With AIDS: Application of an AIDS Casefinding Algorithm , 1998, Health care financing review.

[35]  R. Chaisson,et al.  Racial differences in the use of drug therapy for HIV disease in an urban community. , 1994, The New England journal of medicine.

[36]  D. McCaffrey,et al.  Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, The New England journal of medicine.